Teaching the Immune System to Let Medicines Do Their Job
RARECast - Ein Podcast von RARECast - Donnerstags
Kategorien:
Carsten Brunn, president and CEO of Selecta Biosciences, discusses the problem of immunogenicity to biologics, the company’s ImmTOR platform, and how its leveraging that platform with a growing pipeline of biologics and gene therapies.
